Patents-Review.com
🔗 Permalink
Assignee profile:

Immunotope, Inc.

City:

Doylestown, Pennsylvania

Country:

United States

Published Applications:

10

Last publication date:

2017-06-22

Patent Grants:

8

Last grant date:

2019-02-19

Top Inventors for applications by Immunotope, Inc.

These are the the leading inventors for applications assigned to Immunotope, Inc.:

Recent patent applications by Immunotope, Inc.

Immunotope, Inc. based in Doylestown, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2017-06-22 ✅ Patent 10,206,990 granted on 2019-02-19
US20170173135A1
Human necessities

Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of cancer

 #2 | 2017-05-04 ✅ Patent 10,117,922 granted on 2018-11-06
US20170119869A1
Human necessities

Dengue virus specific multiple HLA binding T cell epitopes for the use of universal vaccine development

 #3 | 2016-12-15 ✅ Patent 10,155,036 granted on 2018-12-18
US20160361410A1
Human necessities

MHC class I associated peptides for prevention and treatment of hepatitis B virus infection

 #4 | 2016-01-28 ✅ Patent 9,907,842 granted on 2018-03-06
US20160022791A1
Human necessities

Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of cancer

 #5 | 2014-08-07 ✅ Patent 9,624,284 granted on 2017-04-18
US20140220117A1
Chemistry; metallurgy

Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of cancer

 #6 | 2014-04-17 ✅ Patent 9,637,521 granted on 2017-05-02
US20140105925A1
Chemistry; metallurgy

Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of dengue virus infection

 #7 | 2012-06-07 ✅ Patent 9,132,178 granted on 2015-09-15
US20120141579A1
Human necessities

Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of cancer

 #8 | 2011-06-16
US20110142919A1
Human necessities

Cytotoxic T-Lymphocyte-Inducing Immunogens for Prevention, Treatment and Diagnosis of Cancer

 #9 | 2008-08-28 ✅ Patent 7,919,467 granted on 2011-04-05
US20080207497A1
Human necessities

Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer

 #10 | 2008-05-08
US20080107668A1
Chemistry; metallurgy

CYTOTOXIC T-LYMPHOCYTE-INDUCING IMMUNOGENS FOR PREVENTION, TREATMENT, AND DIAGNOSIS OF CANCER

Also check out Immunotope, Inc.'s (Doylestown, United States) applicant profile with 1 patent applications submitted.

AssigneeID:

61628 ⎘